CVS Corp (CVS)
63.30 x 500 63.56 x 500
Post-market by (Cboe BZX)
63.48 -1.61 (-2.47%) 02/21/25 [NYSE]
63.30 x 500 63.56 x 500
Post-market 63.36 -0.12 (-0.19%) 19:50 ET
for Fri, Feb 21st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
Sales | 97,710,000 | 95,428,000 | 91,234,000 | 88,437,000 | 93,813,000 |
Cost of Goods | 55,268,000 | 52,948,000 | 49,998,000 | 48,073,000 | 57,419,000 |
Gross Profit | 42,442,000 | 42,480,000 | 41,236,000 | 40,364,000 | 36,394,000 |
Operating Expenses | 40,074,000 | 41,648,000 | 38,191,000 | 38,093,000 | 33,021,000 |
Operating Income | 2,368,000 | 832,000 | 3,045,000 | 2,271,000 | 3,373,000 |
Interest Expense | 758,000 | 752,000 | 732,000 | 716,000 | 690,000 |
Other Income | 516,000 | 25,000 | 24,000 | 25,000 | 22,000 |
Pre-tax Income | 2,126,000 | 105,000 | 2,337,000 | 1,580,000 | 2,705,000 |
Income Tax | 503,000 | 34,000 | 569,000 | 456,000 | 658,000 |
Net Income Continuous | 1,623,000 | 71,000 | 1,768,000 | 1,124,000 | 2,047,000 |
Minority Interests | -21,000 | -16,000 | -2,000 | 11,000 | 1,000 |
Net Income | $1,644,000 | $87,000 | $1,770,000 | $1,113,000 | $2,046,000 |
EPS Basic Total Ops | 1.31 | 0.07 | 1.41 | 0.88 | 1.59 |
EPS Basic Continuous Ops | 1.29 | 0.06 | 1.41 | 0.89 | 1.59 |
EPS Diluted Total Ops | 1.30 | 0.07 | 1.41 | 0.88 | 1.59 |
EPS Diluted Continuous Ops | 1.29 | 0.06 | 1.40 | 0.89 | 1.58 |
EPS Diluted Before Non-Recurring Items | N/A | 1.09 | 1.83 | 1.31 | 2.12 |
EBITDA(a) | $3,515,000 | $1,993,000 | $4,196,000 | $3,409,000 | $4,507,000 |